ProPhase Labs, Inc.

PRPH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-3.8M
Depreciation & Amortization $522.0K
Depreciation —
Amortization —
Stock-Based Compensation $0
Net Cash from Operating Activities $445.0K
Investing Activities
Capital Expenditures $208.0K
Business Acquisitions —
Net Cash from Investing Activities $272.0K
Financing Activities
Dividends Paid —
Stock Repurchases —
Net Cash from Financing Activities $127.0K
Net Change in Cash $844.0K
Free Cash Flow $237.0K
← Newer Page 3 of 3 Older →